Skip to content

Director’s Messages about Clinical Research and Trials

Harnessing the Power of Technology for Mental Health

By Joshua Gordon on

In this Director’s Message, Dr. Gordon discusses the potential that technology holds for expanding the reach of mental health care.

Read More

New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine

By Joshua Gordon on

In his latest message, Dr. Gordon discusses the role of NIMH and other researchers in the development of esketamine, an FDA-approved, rapid-acting medication that targets treatment-resistant depression.

Read More

A Bench-to-Bedside Story: The Development of a Treatment for Postpartum Depression

By Joshua Gordon on

In this message, Dr. Gordon discusses the role of NIMH and others in the bench-to-bedside story of bexanolone, which has just been approved by the FDA as the first treatment specifically for postpartum depression. 

Read More

Summer Reading

By Joshua Gordon on

Dr. Gordon offers highlights of his summer reading in science and literature.

Read More

An Experimental Therapeutic Approach to Psychosocial Interventions

By Joshua Gordon on

Dr. Gordon talks about NIMH’s commitment to support the development and testing of psychosocial interventions in the greater context of the experimental therapeutics approach to treatment research.

Read More